A Phase III Study of Regional Radiation Therapy in Early Breast Cancer
Radiotherapy to the breast reduces the risk of cancer coming back for women with early breast cancer. This international study will determine if treating a larger area with radiotherapy can further improve the results.
Primary Sponsor
NCIC CTG
Collaborating Groups
Trans Tasman Radiation Oncology Group (TROG)
Final Accrual
180
Trial Chairperson
International: Prof Timothy J. Whelan
TROG: A/Prof Boon Chua
Trial Contact
ymurray@ctg.queensu.ca
Clinical Trial Registration
Related Post
5 December, 2024
Extended follow-up of TROG 99.03 lymphoma trial published
5 December 2024: Study shows huge improvement in progression-free
28 November, 2024
Meet TROG President: A/Prof Puma Sandaresan
28 November 2024: In this Q&A, TROG President A/Prof
